Skip to content
Pharma Observatory a Scientist.com platform

Organization (Hospital)

Alberta Health Services

ClinicalTrials.gov lists Alberta Health Services as lead sponsor of 49 trials, counting the companies grouped under it. Alberta Health Services itself has 1 active development program and 10 approved assets.

CA Hospital Manufacturer
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

13 0 1996 2027

Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 3 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 5 in 2026 and about 7 in 2027, the average of the 24 months through September, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored. 1 trial is registered to start in 2027 or later.

Logo Alberta Health Services, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers Alberta Health Services and 3 companies grouped under it: 49 lead-sponsored trials (40 its own, 9 in the grouped companies) and 5 legal-entity registrations (1 its own, 4 in the grouped companies).

Get the Alberta Health Services report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (3)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
Alberta Bone and Joint Health Institute 3 1
Alberta Hip and Knee Clinic 3 1
Royal Alexandra Hospital 3 2

Disease areas (224)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Head and Neck Neoplasms 10
Obesity 10
Pain 9
Prostatic Neoplasms 9
Brain Injuries 7

Trials by start year as sponsor or collaborator (29)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 3
2025 9
2024 13
2023 10
2022 12
2021 13
2020 9
2019 13
2018 12
2017 10

Recruitment duration, a model prediction: none of the 40 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (1)

Active development programs
Drug Disease area Max phase Trials
DP-QB-MYA-002 Mycobacterium Infections, Nontuberculous Phase 1 1

Approved assets (10)

Shown in this order: max phase first.

Approved assets
Drug Trials
Olanzapine 1
Haloperidol 1
Pilocarpine HCl Ophthalmic Solution 1
SUNITINIB 1
"Capecitabine" 1

Journals published in (387)

Shown in this order: most published in first.

Journals published in
Journal Publications
BMJ open 19
The Cochrane database of systematic reviews 11
JAMA 10
Pediatrics 10
Trials 10

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
20 3 2025-06-10

Manufacturing and distribution sites (1)

Manufacturing and distribution sites
Facility Location Regulators Member organization
Alberta Health Services Calgary, CA Health Canada

Organization relationships (101)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
University of Calgary Co sponsors trial with 10
The Hospital for Sick Children Co sponsors trial with 9
St. Justine's Hospital Co sponsors trial with 5
Queen's University Co sponsors trial with 3
University of Alberta Co sponsors trial with 3

Latest dated events (256)

Shown in this order: newest first.

Latest dated events
Date Event Source
2027-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-21 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (74)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
AKT1 Trial collaborator Named in trial inclusion criteria
ALK Trial collaborator Named in trial inclusion criteria
BRAF Trial collaborator Named in trial inclusion criteria
CABIN1 Trial collaborator Named in trial inclusion criteria
CTNNB1 Trial collaborator Named in trial inclusion criteria

Biomarkers this organization publishes on (76)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CRP 6
NPPB 3
CD4 2
CD8A 2
ENO2 2

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.